Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Australian biotech suffers growing pains

Australia's biotech sector has no shortage of good ideas with a total of 30 new companies listing on ASX over the past 20 months. But with too many immature companies, and not enough sophisticated investors, the sector is struggling to achieve stability and growth.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Australia considers revised scheme for young researchers

Harvesting biotechnology

Related external links

eG Capital

Intersuisse

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Neill, G. Australian biotech suffers growing pains. Nat Biotechnol 23, 401–402 (2005). https://doi.org/10.1038/nbt0405-401

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0405-401

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing